News tagged with methylphenidate
Long-term ADHD treatment increases brain dopamine transporter levels, may affect drug efficacy
Long-term treatment of attention deficit/hyperactivity disorder (ADHD) with certain stimulant medications may alter the density of the dopamine transporter, according to research published May 15 in the open access journal ...
Attention deficit disorders
May 15, 2013 |
not rated yet |
0
Long-term ADHD drug use appears safe, brain development not affected
Drugs used to treat Attention Deficit Hyperactivity Disorder (ADHD) do not appear to have long-term effects on the brain, according to new animal research from Wake Forest Baptist Medical Center.
Autism spectrum disorders
Jul 18, 2012 |
5 / 5 (1) |
8
|
Study suggests ADHD drugs may affect male puberty
(Medical Xpress) -- A new study released this week in the Proceedings of the National Academy of Science reveals that the medication methylphenidate, best known as Ritalin, may delay puberty in males. The researchers cautio ...
Attention deficit disorders
Sep 20, 2011 |
4.3 / 5 (3) |
0
|
Is there a link between childhood obesity and ADHD, learning disabilities?
A University of Illinois study has established a possible link between high-fat diets and such childhood brain-based conditions as attention deficit hyperactivity disorder (ADHD) and memory-dependent learning disabilities.
Attention deficit disorders
Feb 19, 2013 |
4 / 5 (1) |
0
|
Parent-focused classes may help tots at risk for ADHD
(HealthDay)—Parent behavior training is an effective and well-studied intervention for preschoolers at risk of developing attention-deficit/hyperactivity disorder (ADHD), a new review shows.
Attention deficit disorders
Apr 01, 2013 |
5 / 5 (1) |
0
|
Mechanism of calming hyperactivity by psychostimulant drugs identified
It has long been known that psychostimulant drugs have the paradoxical effect of reducing hyperactivity. [Psychostimulant drugs include methylphenidate – known by the trade names Ritalin, Concerta, and Methylin – ...
Psychology & Psychiatry
Feb 07, 2012 |
4 / 5 (1) |
0
Stimulant treatment for ADHD not associated with increased risk of cardiac events in youth
Attention-deficit/hyperactivity disorder (ADHD) affects 5-9% of youth and is frequently treated with stimulant medications, such as methylphenidate and amphetamine products. A recent safety communication from the US Food ...
Attention deficit disorders
Feb 08, 2012 |
not rated yet |
0
Study pinpoints effects of different doses of an ADHD drug, finds higher doses may harm learning
New research with monkeys sheds light on how the drug methylphenidate may affect learning and memory in children with attention deficit hyperactivity disorder.
Attention deficit disorders
Mar 08, 2012 |
5 / 5 (2) |
0
|
Prescribed stimulant use for ADHD continues to rise steadily
The prescribed use of stimulant medications to treat attention deficit hyperactivity disorder (ADHD) rose slowly but steadily from 1996 to 2008, according to a study conducted by the National Institutes of Health (NIH) and ...
Attention deficit disorders
Sep 28, 2011 |
5 / 5 (2) |
0
|
Animal study: long-term ritalin doesn't impact growth
(HealthDay) -- Chronic use of methylphenidate (Ritalin) in young monkeys has no significant effect on growth or the dopamine system, or the likelihood of becoming addicted to cocaine, according to a study ...
Psychology & Psychiatry
Jul 20, 2012 |
4.5 / 5 (2) |
0
|
Children with certain dopamine system gene variants respond better to ADHD drug
Children with certain dopamine system gene variants have an improved response to methylphenidate - the most commonly prescribed medication for Attention Deficit Hyperactivity Disorder - in a finding that could help eliminate ...
Attention deficit disorders
Oct 21, 2011 |
5 / 5 (2) |
0
|
Recovery from propofol anesthesia may be sped by use of common stimulant
The ability of the commonly used stimulant methylphenidate (Ritalin) to speed recovery from general anesthesia appears to apply both to the inhaled gas isoflurane, as previously reported, and to the intravenous drug propofol. ...
Medical research
Apr 05, 2012 |
not rated yet |
0
Physicians should not prescribe ADD drugs to healthy people
Physicians in Canada should consider refusing to prescribe cognitive enhancement medications—also used to treat attention deficit disorder (ADD)—to healthy patients, states an analysis article in CMAJ (Canadian Medical A ...
Medications
Dec 17, 2012 |
not rated yet |
0
Treating cocaine dependence: A promising new pharmacotherapy
Medication development efforts for cocaine dependence have yet to result in an FDA approved treatment. The powerful rewarding effects of cocaine, the profound disruptive impact of cocaine dependence on one's lifestyle, and ...
Psychology & Psychiatry
Nov 28, 2012 |
5 / 5 (1) |
0
Illegal drug users more likely to use new synthetic drugs and pharmaceuticals
(Medical Xpress)—Methamphetamine users' use of synthetic cannabis products (such as Kronic) increased from ten per cent in 2010 to 41 per cent in 2011 an annual report on illegal drug use shows. Many of these synthetic ...
Addiction
Oct 18, 2012 |
not rated yet |
0
Methylphenidate
Methylphenidate (Ritalin, MPH) is a psychostimulant drug approved for treatment of attention-deficit hyperactivity disorder, postural orthostatic tachycardia syndrome and narcolepsy. It may also be prescribed for off-label use in treatment-resistant cases of lethargy, depression, neural insult and obesity. Methylphenidate belongs to the piperidine class of compounds and increases the levels of dopamine and norepinephrine in the brain through reuptake inhibition of the monoamine transporters. Methylphenidate possesses structural similarities to amphetamine and its pharmacological effects are more similar to those of cocaine, though MPH is less potent and longer in duration of action.
For more information about Methylphenidate, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
